282 results
S-8
EX-5.1
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
(the “Common Stock”), issuable to eligible individuals under the Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (the “SIP”), (ii) 463,489 shares of Common … the Oruka Therapeutics, Inc. Amended and Restated 2024 Equity Incentive Plan (together with the SIP and ESPP, the “Incentive Plans”) pursuant
S-8
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
Stock Incentive Plan Oruka Therapeutics, Inc. 2024 Employee Stock Purchase Plan Oruka Therapeutics, Inc. Amended and Restated 2024 Equity Incentive … Incentive Plan (the “SIP”), (ii) 463,489 shares of Common Stock issuable under the Oruka Therapeutics, Inc. 2024 Employee Stock Purchase Plan, (iii
S-8
EX-99.3
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
Exhibit 99.3 EMPLOYEE FORM ORUKA THERAPEUTICS, INC. 2024 stock INCENTIVE PLAN GRANT NOTICE FOR STOCK OPTIONS FOR GOOD AND VALUABLE CONSIDERATION … to the conditions set forth in this Grant Notice, the Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (as amended from time to time, the “Plan
S-8
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
the Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (the “SIP”), the Oruka Therapeutics, Inc. 2024 Employee Stock Purchase Plan (the “ESPP … ”), the Oruka Therapeutics, Inc. Amended and Restated 2024 Equity Incentive Plan (the “EIP”), and the Assumed Warrants (as defined below) to prevent dilution
S-8
EX-99.2
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
Exhibit 99.2 Director FORM ORUKA THERAPEUTICS, INC. 2024 stock INCENTIVE PLAN GRANT NOTICE FOR Nonqualified STOCK OPTIONS FOR GOOD AND VALUABLE … the terms and subject to the conditions set forth in this Grant Notice, the Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (as amended from time
8-K
EX-99.1
btg7xeoejbtqu
14 Nov 24
Report of Independent Registered Public Accounting Firm
4:56pm
8-K
EX-10.2
ibors1u tr
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
klo hdnm0ykiv2jmh
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
hi49ksrevm0onbs2cxz
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
8-K
cnps3 w7wm6xvi
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.2
3lhmo43c vvhkglo
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.13
sjna1ie
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.11
exys dxos6
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.4
qnq6 sls8z3dp5g83m
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.10
tdv95sfa
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.3
rw9g55j2ng43
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.16
aq1fxgsjgl1 cgf43
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm